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Abstract:

The current work extends the phenotypic characterization of a bacterial culture collection
obtained from white, yellow, grey or pink microbial cave wall colonies that are common in
the caves of Slovenian Karst. We have determined antibiotic resistance to 22 natural and
synthetic antibiotics in 69 isolates from the microbial mats. Thirty-eight isolates (52%) were
resistant to 1-5 antibiotics; another 27 isolates (37%) were resistant to 6-10 antibiotics;
and 7 isolates (0.1%) were resistant to 11-17 antibiotics. We screened for production of
antimicrobial compounds by growing cave isolates on five different media and overlaying
individual cultures with ten Gram-positive and Gram negative multidrug resistant isolates.
Out of 78 isolates tested, 15.3% showed antimicrobial activity against Escherichia coli DH5,
15.3% against extended-spectrum β-lactamase producing Escherichia coli, 3.8% against
Salmonella enterica serovar Typhimurium TL747, 9% against Klebsiella pneumoniae ATCC
BAA-1706, 9% against carbapenem-resistant Klebsiella pneumoniae ATCC BAA-1705, 7.7%
against Bacillus cereus, 20.5% against Bacillus subtilis, 9% against Listeria monocytogenes,
19.2% against methicillin-resistant Staphylococcus aureus, and 20.5% against methicillinresistant Staphylococcus pseudointermedius. Results showed the potential of cave microbes
to suppress the growth of multi-resistant pathogens, and, a relatively high resistance to
antibiotics.
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INTRODUCTION
The discovery of antibiotics and their successful
clinical use is considered the most significant
development in the history of medicine. However, the
acquisition and spread of antibiotic resistance genes
among pathogenic bacteria has dramatically reduced
the choice and effectiveness of many antibiotics
available today for the treatment of infections in
humans and animals.
The production of antibiotics and resistance
determinants is ubiquitous in bacteria in which
resistance gene products neutralize or detoxify the
secondary metabolites produced by the same or
neighboring cells. Resistance genes are often linked to
and coregulated with the antimicrobial biosynthesis
genes. Hence, the widespread occurrence of antibiotic
resistance in environmental bacteria is an important
indicator of antibiotic production, as seen in soil
(D’Costa et al., 2006; Nodwell, 2007).
*lejla.pasic@ssst.edu.ba

Environmental microbes remain an important source
of novel bioactive compounds due to their ability to
spread and colonize other environments, organisms,
and along the food chain and facilitate the resistance
transfer to other pathogens (Martínez, 2008; Wright,
2010; Bondarczuk et al., 2016; Cycón et al., 2019).
Thus, it is important to establish surveilance and
monitoring of environmental resistances as recently
proposed by WHO as part of a One-health approach
(McEwen & Collignon, 2018).
Today, more than 80 percent of chemotherapeutic
antibiotics originate from secondary metabolism from
well-studied soil Actinobacteria (de Lima Procópio et
al., 2012). Over the past decades, the discovery rate of
natural antibiotics has been steadily declining, moving
the search for novel bioactive molecules towards other
environments, including those considered ‘extreme’
from the anthropocentric point of view.
In this respect we have decided to supplement the
diversity data of microbial mats that colonize the
The author’s rights are protected under a Creative Commons AttributionNonCommercial 4.0 International (CC BY-NC 4.0) license.
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walls of a karst cave (Herzog-Velikonja et al., 2014)
and extend the phenotypic characterization of these
bacterial isolates from the culture collection. Caves
are considered extreme environments due to absence
of light, lack of direct contact with the surface
primary production, permanent climatic conditions,
and scarce and often highly complex nutrients (Lee
et al., 2012).
Previous
culture-independent
studies
have
established that cave microbial mat communities
are dominated by yet-to-be-cultivated members of
Actinobacteria and Proteobacteria (Pašić et al., 2009;
Porca et al., 2012). Cultivation-dependent approach
has resulted in a description of 80 unique isolates,
most of which could not be affiliated with validly
described species and hence likely represent novel
taxa (Herzog-Velikonja et al., 2014).
In this study, we hypothesized that the cave
conditions impact the growth of cave mat bacteria in
the form of delimited mat communities. This would
result in high local production of antimicrobials and
corresponding high resistance to these compounds.
This gives a great potential for further use of isolated
strains as a source of novel bioactive compounds.
To establish the potential of cave microbes as an
antimicrobial resistance source we evaluated the levels

of antibiotic resistance to 22 natural and synthetic
antibiotics. To establish the potential of cave microbes
as a source of novel antimicrobial compounds, we
determined their bactericidal activity against ten
selected Gram-positive and Gram-negative multidrug
resistant clinical isolates.

MATERIALS AND METHODS
Origin of the isolate collection
Bacterial strains were isolated from yellow, grey,
and pink microbial mats from the walls of Pajsarjeva
jama (Pajsar Cave) (Fig. 1A) and taxonomically
evaluated in a previous study (Herzog-Velikonja et
al., 2014). Their taxonomic affiliation is presented in
Figure 1B. Pajsarjeva jama is located 20 km southwest of Ljubljana, Slovenia (45°49'51"N, 14°16'15"E),
is 555 m long, and contains a small stream that flows
underground through the cave. Its air temperature
is 12°C with minor oscillations year-round, and the
humidity reaches 100%. The 80 unique isolates were
obtained in pure cultures on five different growth media
with different nutrient concentration as described
previously (Herzog-Velikonja et al., 2014). The isolates
are preserved in culture collection at Biotechnical
Faculty, University of Ljubljana, Slovenia.

Fig. 1. A) Microbial mats in Pajsarjeva jama under stereomicroscope; photo: L. Pašić, B. Sket; B) Maximum likelihood tree depicting phylogenetic
positioning of 80 Pajsarjeva jama isolates belonging to Actinobacteria (green), Firmicutes (grey), and Proteobacteria (red).

Screening the Pajsarjeva jama isolate collection
for the presence of antibiotic resistance
Bacterial cultures that were grown for 48 h at 30°C
(Laiz et al., 2003) in Mueller-Hinton liquid medium
were diluted to match a 0.5 McFarland turbidity
standard. To obtain uniform growth, we streaked 4
mm-thick Mueller-Hinton agar plates three times with
the cotton swab, rotating the plate for 90° in between

streaks. The plates were air-dried under sterile
conditions for 5 min and discs impregnated with
antibiotics (Hardy Diagnostics, OxoidTM) were then
placed on the surface. To comply with manufacturer’s
instructions, the plates were left at room temperature
for 15 mins and were then incubated for 24 h at
37°C. We then determined the diameter of the zones
of inhibition and classified cultures as resistant as

International Journal of Speleology, 48 (3), 295-303. Tampa, FL (USA) September 2019

Antimicrobial compounds and antibiotic resistance in cave bacteria

per manufacturer’s instructions (Hardy Diagnostics,
OxoidTM). We determined the levels of resistance
to 22 natural and synthetic antibiotics, whose
characteristics are presented in Table 1.
Screening the Pajsarjeva jama isolate collection
for antimicrobial activity
Cultivation conditions
The Pajsarjeva jama bacterial isolates, preserved as
glycerol stocks, were plated onto tryptic soy agar (Difco,
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USA) in quintuplicates and incubated for 48 h at 30°C
as suggested by Laiz et al. (2003). Plates containing
individual isolates were subsequently replica plated
onto five different growth media in triplicates and
incubated for further 48 h at 30°C. The five media
were chosen based on their different ability to elicit
the production of antibiotics and were Mueller-Hinton
agar (Difco, USA), M9 minimal medium with glucose
agar, tryptic soy agar (Difco, USA), Luria-Bertani (LB)
agar (Difco, USA), and Nutrient agar (Difco, USA).

Table 1. Characteristics of antibiotics used in this study.
Mode of action

Antibiotic

Action

Resistance*

Disk potency
(µg)

Inhibitors of cell-wall synthesis
β -lactams
2nd generation
cephalosporine

Modified β-lactams

Ampicillin

Natural

Variable

10

Penicillin

Natural

Variable

10

Cefaclor

Synthetic

Variable

30

Cefotaxime

Synthetic

Moderate

30

Ceftazidime

Synthetic

Moderate

30

Cefpodoxime

Synthetic

Moderate

10

Cefepime

Synthetic

Rare

30

carbapenem

Ertapenem

Synthetic

Moderate

10

carbapenem

Imipenem

Synthetic

Moderate

10

Azithromycin

Synthetic

Moderate

15

Erythromycin

Natural

Moderate

15

Tobramycin

Natural

Widespread

10

Gentamicin

Natural

Widespread

10

Chloramphenicol

Natural

Moderate

30

Florfenicol

Synthetic

Moderate

30

Clindamycin

Synthetic

Moderate

2

Ciprofloxacin

Synthetic

Rare

5

3rd generation
cephalosporine
3rd generation
cephalosporine
4th generation
cephalosporine

Inhibitors of protein synthesis
Macrolides

Aminoglycosides
Lincosamide
Inhibitors of DNA/RNA synthesis
Quinolones
Inhibitor of DNA synthesis, breaks down DNA

Nalidixic acid

Synthetic

Rare

30

Metronidazole

Synthetic

Rare

25

Rifampin

Natural

Moderate

5

Inhibitor of RNA synthesis

Trimethoprim

Synthetic

Moderate

5

Inhibitor of folic acid synthesis

Nitrofurantoin

Synthetic

Rare

300

*The Center for Disease Dynamics Economics and Policy. ResistanceMap: Antibiotic resistance. 2019. https://resistancemap.cddep.org/
AntibioticResistance.php. Date accessed: May 31, 2019.

The production of antimicrobial compounds by cave
isolates was screened as follows. Antibiotic-resistant
indicator strains were grown overnight at 37°C in 10
ml of liquid LB medium. We used ten indicator strains.
Strains Klebsiella pneumoniae ATCC® BAA-1706™
and carbapenem-resistant Klebsiella pneumoniae
ATCC® BAA-1705™ were obtained from the American
Type Culture Collection (USA). Strains Escherichia
coli DH5 (no antibiotic production), Salmonella
enterica serovar Typhimurium TL747, Bacillus cereus
and Bacillus subtilis were obtained from the Genetic
Laboratory Microbe Culture Collection at Department
of Biology, Biotechnical Faculty, University of
Ljubljana, Slovenia. Strains extended- spectrum
β-lactamase producing Escherichia coli Ž39, Listeria
monocytogenes, methicillin-resistant Staphylococcus
aureus, and methicillin-resistant Staphylococcus

pseudointermedius were obtained from the Institute of
Microbiology and Parasitology at Veterinary Faculty,
University of Ljubljana, Slovenia.
Antimicrobial activity screens
The production of antimicrobial compounds from
Pajsarjeva jama isolate collection was established using
soft-agar overlay technique (Hockett & Baltrust, 2017).
Briefly, the Pajsarjeva jama isolate cultures were grown
on agar for 48 h at 30°C, upon which the colonies were
lysed by exposure to chloroform vapors for 10 min.
Residual chloroform was removed by airing the plates
for 20 min, and the cells were overlaid with 3 ml of
soft agar that contained 200 µl of overnight culture of
respective indicator strain. The prepared plates were
incubated at 37°C for 24 h upon which we recorded the
occurrence and the diameter of growth inhibition zones.
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Statistical analysis
In order to identify growth media with significant
effects on antibiotic production, we collected the data
on antibiotic production on different growth media, we
then log(10) transformed the data, performed one-way
ANOVA and calculated the difference between each
pair of means using Fisher’s least significant difference
procedure as implemented in Excel software.

RESULTS
Antibiotic resistance screen
of Pajsarjeva jama isolates
We conducted antibiotic resistance screens on 69
isolates (71% Gram-positive; 29% Gram-negative)
from our culture collection that grew on MullerHinton agar. While resistance to most antibiotics
differed with the organisms tested, all organisms were
sensitive to rifampin.
Antibiotic resistance in Gram-positive isolates
Resistance profile for 48 Gram-positive isolates is
shown in Figure 2. Resistance to the cell-wall inhibitors
was lowest for carbapenem antibiotic imipenem (4.1%)
and cefepime (8.2%), a 4th generation cephalosporine.
Gram-positive isolates were also highly resistant to

modified beta-lactam antibiotics, where resistance levels
ranged from 53.1% (cefaclor) to 65.3% (cefpodoxime).
Within the protein synthesis inhibitor group,
isolates were least resistant to aminoglycoside
gentamicin (2.0% resistant isolates) and macrolide
azithromycin (4.1% resistant isolates). The highest
levels of resistance were recorded for aminoglycosides
florfenicol (59.2%) and clindamycin (65.3%). Isolates
were also highly resistant to DNA synthesis inhibitors
particularly quinolones, i.e. nalidixic acid (79.6%) and
metronidazole (87.8%), while the resistance levels of
inhibitor of RNA synthesis trimethoprim (44.9%) and
folic acid inhibitor nitrofurantoin (40.1%) were in
intermediate range.
With the exception of two Streptomyces isolates
that were sensitive to all antibiotics, all Grampositive isolates were classified as multi-resistant,
that is resistant to at least two antibiotics belonging
to different chemical classes (Godebo et al., 2013;
Exner et al., 2017). Ten isolates were resistant to
1-5 antibiotics; another 19 isolates were resistant
to 6-10 antibiotics; and 17 isolates were resistant
to 11-17 antibiotics. Within the latter group, isolate
Oerskovia sp. B22 was resistant to 17 antibiotics, and
Micrococcus sp. B43 was resistant to 15 antibiotics
(Table 2).

Fig. 2. Antibiotic resistance levels in Pajsarjeva jama isolates belonging to Gram-positive bacteria against
various antibiotics.
Table 2. Range of antibiotic resistance to different antibiotics in Gram-positive isolates with respect to isolate genus.
Genus
Aerococcus

Number of isolates

Number of resistances per isolate

2

8, 14

Agrococcus

1

4

Arthrobacter

2

5,11

Bacillus

1

7

Kocuria

2

6,14

Microbacterium

2

11,13

Micrococcus

9

5, 6, 6, 7, 8, 10, 13, 14, 15

Oerskovia

2

14,17

Paenibacillus

2

7,11

Rhodococcus

8

7, 7, 7, 7, 8, 11, 11, 13

Streptomyces

17

0, 0, 3, 3, 4, 4, 4, 4, 7, 9, 10, 10, 11, 11, 11, 11, 12
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Antibiotic resistance in Gram-negative isolates
Resistance profile for 19 Gram-negative isolates is
shown in Figure 3. Levels of resistance to inhibitors
of cell-wall synthesis ranged from 5.3% for cefepime
to 78.9% for cefaclor. Among inhibitors of protein
synthesis, isolates were highly resistant to macrolide
erythromycin (73.6%) and lincosamide clindamycin
(78.9%), and most sensitive to gentamicin (21.1%
resistant isolates). Among inhibitors of DNA/
RNA synthesis, the isolates were most resistant to
quinolone metronidazole (89.5% resistant isolates),
and least resistant to ciprofloxacin (21.1% resistant
isolates).
All Gram-negative isolates were resistant to at
least four antibiotics from two different groups and
were classified as multi-resistant. Two isolates were
resistant to 4 and 5 antibiotics, another six isolates
were resistant to 6-10 antibiotics, and 11 isolates
were resistant to 11-18 antibiotics. The highest levels
of resistance were found in isolates Mesorhizobium
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sp. B13 (18 antibiotics) and Pseudomonas sp. B34 (15
antibiotics) (Table 3).
Antibiotic production
We tested 78 isolates (29% Gram-negative, 71%
Gram-positive), from our culture collection for the
production of growth inhibiting compounds. Thirtysix isolates (46%) inhibited the growth of at least
one indicator strain. Twenty-three (29.5%) isolates
inhibited the growth of two to nine indicator strains,
while thirteen inhibited the growth of one indicator
strain. The Gram-positive and Gram-negative isolates
were equally effective in inhibiting the growth of
indicator strains: 28 isolates inhibited the growth
of Gram-positive indicator strains and 27 isolates
inhibited the growth of Gram-negative indicator
strains. As depicted in Table 4, most microbial mat
isolates demonstrated unique patterns of antimicrobial
activity. In general, most isolates suppressed the
growth of B. subtilis (20 isolates, 25.6%), S. aureus

Fig. 3. Antibiotic resistance levels in Pajsarjeva jama isolates belonging to Gram-negative bacteria
against various antibiotics.
Table 3. Range of antibiotic resistance to different antibiotics in Gramnegative isolates with respect to isolate genus.
Number
of isolates

Number of resistances
per isolate

Agrobacterium

6

9, 9, 12, 12, 12, 13

Bosea

1

5

Lysobacter

4

7, 7, 10, 12

Mesorhizobium

1

18

Pseudomonas

6

8, 14, 14, 14, 14, 15

Sphingomonas

1

4

Genus

MRSA (20 isolates, 25.6%) and S. pseudointermedius
MRSP (18 isolates, 23.1%), demonstrating their
potential as a tool in combating multi-resistant
pathogenic bacteria. Furthermore, 15.4% of isolates
inhibited the growth of ESBL E. coli Ž39, and 10%
isolates inhibited the growth of Salmonella enterica
subsp. Typhimurium and Listeria monocytogenes. The
growth inhibition was lowest for indicator strains of
Klebsiella pneumoniae and Bacillus cereus (inhibited
by 0.1% of isolates). The three most active isolates

exhibited activity against seven and nine indicator
strains, respectively, and corresponded to Bacillus
sp. B1, Pseudomonas sp. AM82, and Streptomyces sp.
AM91.
The effect of media choice
on antibiotic production
We attempted to trigger 78 bacterial isolates to
produce different secondary metabolites by incubating
them on five different growth media that differed in
nutrient composition. While these media differed in
their ability to elicit production of antibiotics (Table 5),
this difference was not statistically significant
(F = 1.09; P < 0.05).

DISCUSSION
In this study, a bacterial culture collection
originating from the microbial mats that grow on the
walls of Pajsarjeva jama in Slovenia was screened for
the production of antimicrobials and resistance to
antibiotics. Growth of color distinct microbial mats,
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Aerococcus (G+)

B37

+

Bx

+

Kocuria (G+)

+

B35

+

B21

+

+

+

5

+

+

+

4

+

+

+

+

+

+

+

9

+

+

3

+

1

+

+

+

5

+

+

+

+

3

B9

+

+

+

+

3

+
+
+

+

+

B8
AM71

+

AM78

+

+

+

+

+

+

+

+

+

7

+

+

5

+

+

+

5

+

+

+

6
1

AM68

1

+
+

B27

+

+

+

+

+

+

+

2
+

+

+
+

+

+
+

AM84

+

+

+

+
+

+

AM72

+

AM93

1

+

+

+
+

+

+
+

AM108

+

+

+

7
5

+

+

N of isolates

9

12

8

7

7

6

20

8

20

18

% of all isolates

11.5

15.4

10.2

0.1

0.1

0.1

25.6

10.2

25.6

23.1

o

2
1

+
+

5
1

AM90

+

2
1

+

AM74

5
1

AM97
PB4

5
1

+

30

AM91

2
+

+
+

B31

AM66

+
+

+

B36

1
1

+

AM64

B20

1

+

B34

Streptomyces (G+)

6

B25

AM82

Sphingomonas (G-)

+

1
+

B11

Rhodococcus (G+)

S. pseudointermedius
(MRSP)4

+

B32

Pseudomonas (G-)

4

+

B17
Micrococcus (G+)

S. aureus (MRSA)3

B. subtilis

B. cereus

L. monocytogenes

+

Total

+

+

B1
AM121

Lysobacter (G-)

+

+

B60

Bacillus (G+)

+

+

B41

Agrobacterium (G-)

+

K. pneumoniae ATCC® BAA
-1706

+

K. pneumoniae ATCC® BAA
-1705 (CPE)2

B18

S. enterica s. Typhimurium
TL 747

Isolate name

E. coli Ž391 (ESBL)

Taxonomic affiliation/
Gram stain

E. coli DH5

Table 4. Antimicrobial activity of individual Pajsarjeva jama isolates against 10 selected pathogenic indicator strains. The isolates are grouped
according to their taxonomic affiliation at genus level.

2

Legend: 1ESBL – extended spectrum beta-lactamase; 2CPE – carbapenem resistant enterobacterium; 3MRSA – methicillin-resistant S. aureus;
4
MRSP – methicillin-resistant S. pseudointermedius
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Table 5. Numbers of Pajsarjeva jama isolates showing antimicrobial activity with respect to growth medium.
Number of isolates with antimicrobial activity

Indicator strain

TSA

MHM

MG

LB

HA

E. coli DH5

3

2

5

2

2

E. coli Ž39 (ESBL)

7

4

4

2

3

S. enterica s. typhi TL 747

3

1

6

0

0

K. pneumoniae ATCC® BAA -1705 (CPE)2

5

2

2

4

3

K. pneumoniae ATCC® BAA -1706

3

2

2

4

5

B. cereus

4

3

3

4

3

B. subtilis

8

17

8

10

16

L. monocytogenes

4

3

6

4

4

S. aureus (MRSA)3

11

11

9

10

10

8

14

10

10

10

S. pseudointermedius (MRSA)4

Legend: ESBL – extended spectrum beta-lactamase; CPE – carbapenem resistant enterobacterium;
3
MRSA – methicillin-resistant S. aureus; 4MRSP – methicillin-resistant S. pseudointermedius
1

2

white, yellow, grey or pink on the walls and sediments
of karst caves is common in many caves. Cave mats
can be observed in completely dark areas of the caves,
often concentrated in the proximity of underground
waters and sediments, but never in submerged areas.
Past studies have shown that the dominant bacterial
taxa in cave microbial mats corresponds to members
of Actinobacteria and Proteobacteria as reported in
other caves (Pašić et al., 2009; Northrup et al., 2011;
Porca et al., 2012; Brag & Bergmann, 2019). However,
since physicochemical conditions and nutrient
availability differ in caves worldwide and even within
a single cave, we were able to obtain culture collection
of taxonomically novel bacterial isolates (HerzogVelikonja et al., 2014).
We surveyed the antibiotic susceptibility of 69
culture collection isolates to 22 natural and synthetic
antibiotics. The levels of antibiotic resistance were
high, with majority of Gram-positive isolates being
resistant to one to seventeen antibiotics and Gramnegative isolates being resistant to four to eighteen
antibiotics. Certain amount of this resistance is
intrinsic: we observed no resistance to antibiotic
rifampin, which is used to treat infections with
acid-fast microorganisms, such as Mycobacterium
tuberculosis and Mycobacterium leprae. Likewise, high
levels of resistance to antibiotic metronidazole (88% in
Gram-positive and 90% in Gram-negative isolates) are
likely a consequence of metronidazole acting primarily
on anaerobic microorganisms indicating also low
abundance of anaerobes in cave microbial mats. Other
differences stem from different structure of Gramnegative cell wall and versatile resistance mechanisms
in this group of bacteria. We measured comparatively
less resistance to natural antibiotics than to synthetic
antibiotics. This was somewhat surprising, as
natural products are more likely to be present in
the environment. Besides, in a study on Lechuguilla
Cave, a pristine environment free from anthropogenic
influences, the opposite trend was observed (Bhullar
et al., 2012). All isolates were comparatively most
resistant to modified β-lactams (resistance levels
30-80%), particularly to cephalosporines of second
and third generation. Interestingly, low levels or
resistance (<10%) were found even for cefepime, a
recently introduced 4th generation cephalosporine. In

these terms, the results of our study are consistent
with previous studies which have noted high levels
of antibiotic resistance genes in cave environments
(Pawlowski et al., 2016; Lavoie, 2017; Belyagoubi et
al., 2018) and even in ancient cave microbes that had
no anthropogenic contact for the past four million
years (Bhullar et al., 2012).
Our culture collection contained isolates from genera
whose members are well-known human and animal
pathogens, often resistant to multiple antibiotics
which makes treatment and patient recovery difficult.
Examples are agents of nosocomial infections
Pseudomonas and Sphingomonas (Obritsch et al.,
2005; Göker et al., 2017), emerging pathogen Kocuria
(Purty et al., 2013), opportunistic pathogen Oerskovia
(Cruickshank et al., 1979) and honeybee pathogen
Paenibacillus (Grady et al., 2016). In these terms
we found establishing antibiotic resistance patterns
important, as growing body of evidence suggests
that non-pathogenic environmental organisms are a
reservoir of resistance genes that have the potential
to be transferred to pathogens (Riesenfeld et al., 2004;
Allen et al., 2010).
Pseudomonas aeruginosa is the most important
pathogen in the genus and displays resistance to a
variety of antibiotics, including aminoglycosides,
quinolones and β-lactams (Hancock & Speert,
2000). In our study, Pseudomonas members were
also resistant to macrolides erythromycin (83% of
Pseudomonas strains) and azithromycin (50% of
Pseudomonas strain). All members of Kocuria are
resistant to nitrofurantoin (Savini et al., 2010), which
is consistent with our results, while resistance to
other antibiotics varied among isolates. Similar to
pathogenic isolates, our Sphingomonas isolate was
resistant to 3rd generation cephalosporins cefotaxime
and cefpodoxime (Bayram et al., 2013).
Most isolates in our culture collection belong to
bacterial genera that are well known sources of
bioactive compounds. Apart from members of genus
Streptomyces, we obtained members of Lysobacter,
a known prolific producer of bioactive peptides (Xie
et al., 2012) and members of Kocuria, Arthrobacter
and Rhodococcus, producers of compounds with
antimicrobial, antifungal, and cytotoxic activities
against human cells (Elsayed, 2017; Singh et al., 2017).
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Previous studies on cave environments have noted
antibiotic production (Yücel & Yamaç, 2010; Bhullar
et al., 2012; Montano & Henderson., 2012; Tomova
et al., 2013, Pawlowski et al., 2016; Riquelme et al.,
2017) and resulted in a description of Xiakemycin A, a
novel pyranonaphthoquinone antibiotics produced by
a cave Streptomyces sp. (Jiang et al., 2015).
In this study almost half (46%) of tested isolates
inhibited the growth of at least one indicator strain.
The isolates were most active against multi-resistant
Bacillus and Staphylococcus species (inhibited by 25%
and 23% of tested isolates), Klebsiella pneumoniae,
and Listeria monocytogenes (inhibited by 10% of
tested isolates). These levels of inhibition were higher
than those observed in a study on actinomycetes
originating from a volcanic cave, where 26.5% of
isolates inhibited K. pneumoniae, 2.0% inhibited S.
aureus, and 1% inhibited ESBL E. coli (Cheeptham et
al., 2013). The results of these two studies combined
demonstrate the potential of cave microorganisms to
suppress the growth of multi-resistant pathogens.
In our study, the three most bioactive isolates
belonged to genera Bacillus, Pseudomonas, and
Streptomyces and inhibited seven to nine indicator
strains. Important levels of inhibition were also
observed with Lysobacter and Kocuria members,
which inhibited the growth of five indicator strains.
The exact nature and mechanisms of growthinhibiting compounds remains to be established in
further studies.
In conclusion, this study suggests a high possibility
of finding novel antimicrobial compounds in microbes
that inhabit underground environments, while
antimicrobial resistance patterns contribute to
knowledge on environmental resistances and their
presence in the environment.
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